In a move to block Gilead’s patent on Sovaldi in India, Natco has filed a pre-grant opposition to its pending application. Reuters reports that the opposition has been made on the ground that the drug is not “inventive”. Fairy tales have taught us that all magic comes at a price. Little do we realize that this lesson can apply in the real world! Sovaldi, hailed a ‘wonder drug’ with a purported cure rate of 90% for Hepatitis C and a short duration...
↧